CYNA News

Eight IPOs raised $2.3 billion this past week. High-growth consumer deals Fitbit and Fogo de Chão came out on top. This week featured a diverse set technology, consumer, energy, health care and industrial IPOs, none of which priced below the proposed midpoint. The largest first-day pops and drops tend to come from smaller companies, but Fitbit ($5 billion...read more

Cynapsus Therapeutics, which is developing an easier-to-use formulation of apomorphine for Parkinson's disease, raised $63 million by offering 4.5 million shares at $14, below the most recent closing price of $14.80 (C$18.25) on the Toronto Stock Exchange. As announced in a filing late Wednesday afternoon, Dexxon, which is Cynapsus' largest shareholder, invested $10 million at the...read more

Fitbit leads this week's 11 companies looking to raise over $1.7 billion through US initial public offerings. A good FIT Fitbit (FIT) flexes its muscle with the week's largest IPO; the deal size is set at $448 million, though it could raise more based on investor demand. Fitbit has...read more

Cynapsus Therapeutics, which is developing a sublingual formulation of an approved therapy for Parkinson's disease, announced terms for its IPO on Tuesday. Cynapsus is currently listed on the Toronto Stock Exchange under the symbol CTH with a basic market cap of about $100 million. The Toronto, Canada-based company plans to offer 4.5 million shares, which would generate...read more